DANNY FILLIP: Open Payments
NPI 1992745053 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,972 in 232 payments from 26 companies in 2025. Trend: 2023 $2,788 · 2024 $3,800 · 2025 $3,972
Food & beverage: $3,972
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $478 |
| Vanda Pharmaceuticals Inc. | 15 | $374 |
| ABBVIE INC. | 27 | $315 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $302 |
| Axsome Therapeutics, Inc. | 9 | $299 |
| Lundbeck LLC | 15 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $286 |
| Teva Pharmaceuticals USA, Inc. | 7 | $225 |
| Novartis Pharmaceuticals Corporation | 26 | $211 |
| PFIZER INC. | 14 | $207 |
Products named: FANAPT, REXULTI, Kerendia, CAPLYTA, Wegovy, LEQVIO, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
